• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.

作者信息

Harrison Claire N, Butt Nauman, Campbell Peter, Conneally Eibhlin, Drummond Mark, Green Anthony R, Murrin Richard, Radia Deepti H, Mead Adam, Reilly John T, Cross Nicholas C P, McMullin Mary F

机构信息

Department of Haematology, Guy's and St Thomas, Hospitals' NHS Foundation Trust, London, UK.

出版信息

Br J Haematol. 2014 Nov;167(3):421-3. doi: 10.1111/bjh.12986. Epub 2014 Jun 17.

DOI:10.1111/bjh.12986
PMID:24935860
Abstract
摘要

相似文献

1
Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.英国血液学标准委员会原发性血小板增多症诊断标准的修订
Br J Haematol. 2014 Nov;167(3):421-3. doi: 10.1111/bjh.12986. Epub 2014 Jun 17.
2
Essential thrombocythaemia with mutation in : clinicopathological correlation and comparison with 2V617F-mutated and mutated genotypes.伴有 JAK2 V617F 突变的原发性血小板增多症：临床病理相关性及与 JAK2 V617F 突变和突变基因型的比较
J Clin Pathol. 2018 Nov;71(11):975-980. doi: 10.1136/jclinpath-2018-205227. Epub 2018 Jun 22.
3
Essential Thrombocythemia.原发性血小板增多症
N Engl J Med. 2019 Nov 28;381(22):2135-2144. doi: 10.1056/NEJMcp1816082.
4
Different Shapes Of Megakaryocytes In Essential Thrombocythemia.特发性血小板增多症中的巨核细胞形态各异。
J Ayub Med Coll Abbottabad. 2022 Apr-Jun;34(2):389-391. doi: 10.55519/JAMC-02-9227.
5
[Immunohistochemical method of megakaryocytic lineage staining in bone marrow biopsy specimens as an additional pathomorphological differential diagnostic sign of primary myelofibrosis and essential thrombocythemia].[骨髓活检标本中巨核细胞系染色的免疫组织化学方法作为原发性骨髓纤维化和原发性血小板增多症的附加病理形态学鉴别诊断标志]
Arkh Patol. 2025;87(1):22-27. doi: 10.17116/patol20258701122.
6
Essential thrombocythemia: a review of diagnostic and pathologic features.原发性血小板增多症：诊断与病理特征综述
Arch Pathol Lab Med. 2006 Aug;130(8):1144-50. doi: 10.5858/2006-130-1144-ET.
7
Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia.内源性巨核细胞集落强调原发性血小板增多症中巨核细胞与钙网蛋白突变之间的关联。
Haematologica. 2015 May;100(5):e176-8. doi: 10.3324/haematol.2014.118927. Epub 2015 Feb 6.
8
Impact of white blood cell counts at diagnosis and during follow-up in patients with essential thrombocythaemia and prefibrotic primary myelofibrosis.原发性血小板增多症和纤维化前原发性骨髓纤维化患者诊断时及随访期间白细胞计数的影响
Br J Haematol. 2017 Oct;179(1):166-169. doi: 10.1111/bjh.14202. Epub 2016 Jul 19.
9
Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.真性红细胞增多症研究组关于修订原发性血小板增多症和真性红细胞增多症诊断标准的提议。
Semin Thromb Hemost. 1997;23(4):339-47. doi: 10.1055/s-2007-996107.
10
Essential thrombocythaemia and its neurological complications.原发性血小板增多症及其神经系统并发症。
Pract Neurol. 2010 Aug;10(4):195-201. doi: 10.1136/jnnp.2010.219956.

引用本文的文献

1
Evolution of WHO diagnostic criteria in "Classical Myeloproliferative Neoplasms" compared with the International Consensus Classification.世界卫生组织（WHO）“经典骨髓增殖性肿瘤”诊断标准与国际共识分类的演变
Blood Cancer J. 2025 Mar 4;15(1):31. doi: 10.1038/s41408-025-01235-7.
2
The aetiology and burden of myeloproliferative neoplasms in the United Kingdom: the MyelOproliferative neoplasmS: an In-depth case-control (MOSAICC) study protocol.英国骨髓增殖性肿瘤的病因和负担：骨髓增殖性肿瘤 S：深入病例对照（MOSAICC）研究方案。
BMC Cancer. 2023 Dec 7;23(1):1207. doi: 10.1186/s12885-023-11483-0.
3
Causes of Thrombocytosis: A Single-center Retrospective Study of 1,202 Patients.
血小板增多症的病因：一项 1202 例患者的单中心回顾性研究。
Intern Med. 2022;61(22):3323-3328. doi: 10.2169/internalmedicine.9282-21. Epub 2022 Nov 15.
4
Essential Thrombocythemia among Patients with Myeloproliferative Neoplasms in Haematology Unit of a Tertiary Care Centre: A Descriptive Cross-sectional Study.在一家三级护理中心血液科的骨髓增殖性肿瘤患者中的特发性血小板增多症：一项描述性横断面研究。
JNMA J Nepal Med Assoc. 2022 Apr 15;60(248):369-373. doi: 10.31729/jnma.7359.
5
Low-Risk Essential Thrombocythemia: A Comprehensive Review.低风险原发性血小板增多症：全面综述
Hemasphere. 2021 Jan 27;5(2):e521. doi: 10.1097/HS9.0000000000000521. eCollection 2021 Feb.
6
Classification and Personalized Prognosis in Myeloproliferative Neoplasms.骨髓增殖性肿瘤的分类与个体化预后
N Engl J Med. 2018 Oct 11;379(15):1416-1430. doi: 10.1056/NEJMoa1716614.
7
Epigenetics in Myeloproliferative Neoplasms.骨髓增殖性肿瘤中的表观遗传学。
J Cell Mol Med. 2017 Sep;21(9):1660-1667. doi: 10.1111/jcmm.13095. Epub 2017 Jul 4.
8
Response to Harrison et al. 'Clinically relevant differences between BCSH and WHO diagnostic criteria for ET'.对哈里森等人《英国血液学标准委员会（BCSH）与世界卫生组织（WHO）真性红细胞增多症诊断标准的临床相关差异》一文的回应
Leukemia. 2017 Mar;31(3):768-769. doi: 10.1038/leu.2016.319. Epub 2016 Nov 29.
9
Equivalence of BCSH and WHO diagnostic criteria for ET.英国血液学标准委员会（BCSH）与世界卫生组织（WHO）关于原发性血小板增多症（ET）诊断标准的等效性。
Leukemia. 2017 Feb;31(2):527-528. doi: 10.1038/leu.2016.318. Epub 2016 Nov 29.
10
[Chinese expert consensus on the diagnosis and treatment of essential thrombcythaemia(2016)].[原发性血小板增多症诊断与治疗中国专家共识（2016年版）]
Zhonghua Xue Ye Xue Za Zhi. 2016 Oct 14;37(10):833-836. doi: 10.3760/cma.j.issn.0253-2727.2016.10.001.